文献速递类风湿关节炎

甲氨蝶呤与BAFF相互作用防止针对TNF抑制剂的免疫

Methotrexate and BAFF interaction prevents immunization against TNF inhibitors.
PubMed 文献 · Ann Rheum Dis · 2018-06-23

研究在BAFF转基因小鼠、猕猴及ABIRISK队列类风湿关节炎患者中探索甲氨蝶呤降低TNF抑制剂免疫原性的机制。BAFF转基因小鼠中单疗程甲氨蝶呤可预防抗药抗体产生并维持药物浓度超过52周,CD73、腺苷及调节性B细胞参与其中。ABIRISK队列中高血清BAFF水平仅在与甲氨蝶呤联用的患者中与无抗药抗体相关。

要点

  • BAFF转基因小鼠中单疗程甲氨蝶呤预防抗TNF抑制剂免疫并维持药物浓度超过52周。
  • BAFF转基因小鼠B细胞CD73和CD39表达高于野生型,甲氨蝶呤诱导B细胞释放腺苷并增加调节性B细胞。
  • ABIRISK队列中高血清BAFF仅在与甲氨蝶呤联用患者中与无抗药抗体相关。

核心结论

  • 甲氨蝶呤与BAFF在小鼠中相互作用,CD73、腺苷和调节性B细胞被确定为该现象的关键参与者。
  • 甲氨蝶呤与BAFF在患者中也相互作用以预防抗药抗体形成。

研究设计与样本

  • 研究使用BAFF转基因小鼠(自身免疫病模型,对生物制剂免疫原性高)给予不同TNF抑制剂,并比较野生型与BAFF转基因小鼠B细胞表面标志物。
  • 研究将结果转化至猕猴和ABIRISK队列中接受TNF抑制剂治疗的类风湿关节炎患者,以确定血清BAFF水平与甲氨蝶呤之间是否存在预防免疫的相互作用。

主要发现

  • 在BAFF转基因小鼠而非野生型小鼠或猕猴中,单疗程甲氨蝶呤预防了针对TNF抑制剂的免疫并维持药物浓度超过52周。
  • BAFF转基因小鼠B细胞较野生型表达更多CD73和CD39。
  • 甲氨蝶呤诱导B细胞释放腺苷并增加调节性B细胞及其前体。
  • 使用CD73阻断抗体逆转了甲氨蝶呤诱导的耐受。
  • 在ABIRISK队列中接受TNF抑制剂治疗的慢性炎症性疾病患者中,高血清BAFF水平仅在与甲氨蝶呤联用的患者中与无抗TNF抑制剂抗药抗体相关,而在TNF抑制剂单药治疗患者中不相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: TNF inhibitors (TNFi) can induce anti-drug antibodies (ADA) in patients with autoimmune diseases (AID) leading to clinical resistance. We explored a new way of using methotrexate (MTX) to decrease this risk of immunisation. METHODS: We treated BAFF transgenic (BAFFtg) mice, a model of AID in which immunisation against biologic drugs is high, with different TNFi. We investigated the effect of a single course of MTX during the first exposure to TNFi. Wild-type (WT) and BAFFtg mice were compared for B-Cell surface markers involved in MTX-related purinergic metabolism, adenosine production and regulatory B-cells (Bregs).We translated the study to macaques and patients with rheumatoid arthritis from the ABIRISK cohort to determine if there was an interaction between serum BAFF levels and MTX that prevented immuniation. RESULTS: In BAFFtg but not in WT mice or macaques, a single course of MTX prevented immunisation against TNFi and maintained drug concentration for over 52 weeks. BAFFtg mice B-cells expressed more CD73 and CD39 compared to WT mice. MTX induced adenosine release from B cells and increased Bregs and precursors. Use of CD73 blocking antibodies reversed MTX-induced tolerance. In patients from the ABIRISK cohort treated with TNFi for chronic inflammatory diseases, high BAFF serum level correlated with absence of ADA to TNFi only in patients cotreated with MTX but not in patients on TNFi monotherapy. CONCLUSION: MTX and BAFF interact in mice where CD73, adenosine and regulatory B cells were identified as key actors in this phenomenon. MTX and BAFF also interact in patients to prevent ADA formation.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Bitoun S, Nocturne G, Ly B, et al. Methotrexate and BAFF interaction prevents immunization against TNF inhibitors. Ann Rheum Dis. 2018. PMID: 29936438. doi:10.1136/annrheumdis-2018-213403

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。